Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Obsidian Therapeutics Inc.
Market Cap
$13.75M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.86M
Operating Margin
-1053.14%
TTM Avg
-1090.26%
3Y Avg
-1143.76%
5Y Avg
-1293.19%
Market Cap
$14.05M
Operating Margin
-30.39%
TTM Avg
-233.67%
3Y Avg
-448.22%
5Y Avg
-530.52%
Market Cap
$13.30M
Operating Margin
-1062.29%
TTM Avg
-1250.55%
3Y Avg
-3518.84%
5Y Avg
-2345.89%
Market Cap
$13.20M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$14.46M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
Market Cap
$12.78M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $13.75M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -1053.14% | -1090.26% | -1143.76% | -1293.19% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | -30.39% | -233.67% | -448.22% | -530.52% |
| IN8bio, Inc. (INAB)vs › | $13.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -1062.29% | -1250.55% | -3518.84% | -2345.89% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -859.22% | -477.88% | -341.34% | -316.87% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -56.17% | -72.17% | -80.90% | -88.24% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
